All-cause mortality and causes of death in the Swiss Hepatitis C Cohort Study
M. Roelens(BIOASTER), Olivia Keiser(University of Geneva), Francesco Negro(University Hospital of Geneva), Christoph Junker(Federal Statistical Office), Beat Müllhaupt(University Hospital of Zurich), Nasser Semmo, Darius Moradpour(University Hospital of Lausanne), David Semela(Kantonsspital St. Gallen), Olivier Clerc(Hospital Neuchâtel), Andreas Cerny(Epatocentro Ticino), Barbara Bertisch(Kantonsspital St. Gallen), Patrick Schmid(Kantonsspital St. Gallen)
Cited by 0
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857